Advertisement
Poster Session (Saturday 28 January 2017): Outcome Research: POSTER| Volume 72, SUPPLEMENT 1, S136, February 2017

Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated non-squamous (NSQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs)

DOI:https://doi.org/10.1016/S0959-8049(17)30524-5
Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated non-squamous (NSQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs)
Previous ArticleLong-term survivorship for patients with non-small cell lung cancer (NSCLC) treated with nivolumab (nivo): a response-based modeling approach
Next ArticleComparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated squamous (SQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs)
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0959-8049(17)30524-5

      Copyright

      © 2017 Elsevier Ltd. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX